Skip to main content
Acta Pharmacologica Sinica logoLink to Acta Pharmacologica Sinica
. 2009 May 18;30(6):673–680. doi: 10.1038/aps.2009.64

Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system

Jian-xin Shen 1,2,*, Jerrel L Yakel 1,*
PMCID: PMC4002362  PMID: 19448647

Abstract

Based on the composition of the five subunits forming functional neuronal nicotinic acetylcholine receptors (nAChRs), they are grouped into either heteromeric (comprising both α and β subunits) or homomeric (comprising only α subunits) receptors. The nAChRs are known to be differentially permeable to calcium ions, with the α7 nAChR subtype having one of the highest permeabilities to calcium. Calcium influx through nAChRs, particularly through the α-bungarotoxin-sensitive α7-containing nAChRs, is a very efficient way to raise cytoplasmic calcium levels. The activation of nAChRs can mediate three types of cytoplasmic calcium signals: (1) direct calcium influx through the nAChRs, (2) indirect calcium influx through voltage-dependent calcium channels (VDCCs) which are activated by the nAChR-mediated depolarization, and (3) calcium-induced calcium release (CICR) (triggered by the first two sources) from the endoplasmic reticulum (ER) through the ryanodine receptors and inositol (1,4,5)-triphosphate receptors (IP3Rs). Downstream signaling events mediated by nAChR-mediated calcium responses can be grouped into instantaneous effects (such as neurotransmitter release, which can occur in milliseconds after nAChR activation), short-term effects (such as the recovery of nAChR desensitization through cellular signaling cascades), and long-term effects (such as neuroprotection via gene expression). In addition, nAChR activity can be regulated by cytoplasmic calcium levels, suggesting a complex reciprocal relationship. Further advances in imaging techniques, animal models, and more potent and subtype-selective ligands for neuronal nAChRs would help in understanding the neuronal nAChR-mediated calcium signaling, and lead to the development of improved therapeutic treatments.

Keywords: nicotinic acetylcholine receptors, calcium, cellular signaling, nervous system

Introduction

Neuronal nicotinic acetylcholine (ACh) receptors (nAChRs) are in the cys-loop ligand-gated ion channel superfamily, and are activated by nicotine in addition to the endogenous neurotransmitter ACh. The nAChRs are widely expressed in the brain, located both at the synapse (presynaptically and postsynaptically) as well as extrasynaptically1, 2. Presynaptic and preterminal nAChRs can enhance neurotransmitter release, postsynaptic nAChRs can contribute to fast excitatory transmission, and extrasynaptic nAChRs can modulate many neurotransmitter systems by influencing neuronal excitability and/or intracellular processes1, 2, 3. The nAChRs play important modulatory roles in neuronal development and synaptic plasticity, participating in cognitive functions such as learning, memory, and attention. In addition, decrease, disruption or alteration in the function of neuronal nAChRs contributes to dysfunctions associated with various neurodegenerative diseases and disorders, including (but not limited to) epilepsy, schizophrenia, Parkinson's disease, autism, Alzheimer's disease, and addiction1, 4.

Neuronal nAChRs are pentameric transmembrane proteins, consisting of five subunits from a portfolio of nine α (α2–α10) and three β (β2–β4) subunits5, 6, 7. Some are homomeric nAChRs, such as α7 receptors which contain five α7 subunits, and others are heteromeric nAChRs, which comprise α and β subunits1. Different subtypes of neuronal nAChRs are known to be differentially permeable to calcium ions (Ca2+)2, 3, 8. The α7 nAChR subtype has one of the highest permeabilities to calcium7, the activation of which can raise cytoplasmic calcium levels and trigger a series of calcium-dependent intracellular processes. Calcium ions are one of the most versatile intracellular messengers known, and impacts almost every aspect of cellular life, including excitability, exocytosis, motility, apoptosis, and transcription; this is achieved by interacting with thousands of proteins and their downstream effectors9, 10. Calcium influx through nAChRs, particularly through the α-bungarotoxin-sensitive α7-containing nAChRs, is a very efficient way to raise cytoplasmic calcium levels. Here we will present a brief summary of the calcium signals initiated by the activation of neuronal nAChRs, and its possible physiological relevance.

Cytoplasmic calcium signals initiated by neuronal nAChR activation

There are three types of cytoplasmic calcium signals initiated by neuronal nAChR activation; (1) direct calcium influx through the nAChR6, 11, (2) indirect calcium influx through voltage-dependent calcium channels (VDCCs) which are activated by the nAChR-mediated depolarization6, 11, and (3) calcium-induced calcium release (CICR) (triggered by the two sources listed above) from the endoplasmic reticulum (ER) through the ryanodine receptors12, 13, 14 and inositol (1,4,5)-triphosphate receptors (IP3Rs)13, 14, 15.

Direct calcium influx through nAChRs

Two primary methods have been developed for estimating the calcium permeability of nAChRs. The first utilizes the shift in the reversal potential of nAChR-mediated currents due to changes in the extracellular calcium concentration. The permeability ratio PCa/PNa, which is the relative permeability of calcium to sodium ions, was then estimated using the Goldmann-Hodgkin-Katz constant field equation16, 17. The PCa/PNa ratio estimated in this way was ∼2 for heteromeric neuronal non-α7 nAChRs, and >10 for homomeric α7 or the heteromeric α9/α10 nAChRs2, 3, 7, 8. However, this relative approach has serious limitations.

The second method for estimating the calcium permeability of nAChRs is based on fluorescent calcium indicators7, 18, 19, 20. This approach relies on the simultaneous recording of fluorescence signals and transmembrane currents, and requires perfect voltage control of the cell and the absence of CICR. In this way, the percentage of the total current flowing through a given ion channel that is carried by calcium ions, the so-called “fractional calcium current” (usually indicated as Pf), can be measured. Heteromeric neuronal nAChRs have a Pf of 2%–5%, whereas homomeric α7 nAChRs (which have the highest Pf) range from 6%–12% (depending on the species)7, 21.

Interestingly, for the α3 subunit-containing human nAChRs, incorporation of the α5 subunit significantly increases calcium permeability22. Populations of nAChRs composed of α4 and β2 subunits with different stoichiometries can be expressed in oocytes with different functional properties; eg the (α4)3(β2)2 stoichiometry has been demonstrated to have a much greater Ca2+ permeability than does the (α4)2(β2)3 stoichiometry23.

Indirect calcium influx through VDCCs

Activation of nAChRs can depolarize neurons, inducing the activation of the VDCCs and subsequent calcium influx. The nAChRs that contain α3 and/or β2 subunits in brain and ganglionic neuronal preparations are associated predominantly with calcium signals that are mediated by depolarization and the activation of VDCCs12, 14, 24, as well as the α7 nAChRs25, 26. Calcium influx through VDCCs augments the primary calcium signals generated by the direct influx through nAChRs11, 14. These two mechanisms may be physiologically complementary; calcium entry through inwardly rectifying nAChRs will be robust under either resting or hyperpolarized potentials, whereas calcium influx through VDCCs will occur mainly at more depolarized potentials (−40 mV)27.

Intracellular calcium release from internal stores

In addition to the entry of extracellular calcium through channels in the plasma membrane, the cytoplasmic concentration of calcium reflects a complex interplay between buffering and mobilization capacities. In particular, calcium release from intracellular stores (via CICR) can have a crucial role in defining calcium responses28. The activation of α7 nAChRs can generate calcium transients via entry through the channel pore itself (independently of VDCCs), which can then activate CICR from ryanodine-dependent stores12, 13, 14. In neurons of the substantia nigra pars compacta, depletion of internal calcium stores inhibits the increase in cytoplasmic calcium levels induced by nicotine and the α7 nAChR-selective agonist choline12. Blockade of ryanodine receptors in neuroblastoma cells also significantly reduces the increase in cytoplasmic calcium induced by activation of β2 and α7 subunit-containing nAChRs14. Functional coupling between α7 nAChRs and ryanodine receptors has also been observed in cultured hippocampal astrocytes, where α7 nAChR-mediated calcium signals arise primarily from CICR through ryanodine receptors13.

Cytoplasmic calcium signals can also be enhanced by activation of the IP3 receptor (IP3R) second-messenger system and the subsequent release of calcium from intracellular stores. The involvement of IP3R-dependent calcium stores in neuronal nAChR signaling was shown when nAChR-induced calcium responses were reduced with IP3R-selective antagonists13, 14, 15. The functional interaction between IP3 and ryanodine receptor-dependent calcium signals is considered to be a key signaling mechanism28. Reports that nAChR-induced release of calcium from IP3Rs is secondary to that from ryanodine receptors are consistent with their sequential activation13, 14. Although it is unclear how nAChR stimulation activates IP3Rs, possible mediators are a calcium-dependent phospholipase C (PLC)29, and/or calcium-sensor proteins30 activated following nAChR activation. The ability to activate different sources of calcium confers a further spatial and temporal dimension to the calcium signals evoked by nAChR activation. By converting acute nAChR stimulation into sustained cellular events, calcium signals may be a crucial link between nAChRs and the downstream processes that impinge on many neuronal functions.

Another source of intracellular Ca2+ stores includes the mitochondria31. The ER-mitochondrial interactions are important for the continued filling of the ER32, 33. The efflux of Ca2+ from the mitochondria through the mitochondrial Na+/Ca2+ exchanger can contribute to the overfilling of some intracellular Ca2+ stores, particularly those that are in extremely close proximity to mitochondria34, 35. The repeated activation of nAChRs can enhance calcium release from mitochondria36, 37.

Downstream signaling events mediated by nAChR-mediated calcium responses

Calcium signals initiated by the activation of nAChRs can initiate responses via a variety of different mechanisms. According to the duration and timing, we have grouped these into instantaneous effects, short-term effects, and long-term effects.

Instantaneous effects

Regulation of cytoplasmic calcium levels The immediate impact of nAChR activation is the direct influx of cations (including calcium ions) through the channel pore. This instantaneous membrane depolarization can then activate the VDCCs, thereby increasing cytoplasmic calcium levels. Both the direct calcium influx through nAChRs, and indirect calcium influx through VDCCs, can then trigger calcium release from intracellular calcium stores as noted above6. In chick ciliary ganglion neurons, a major portion of the nAChR-induced changes in cytoplasmic calcium levels is due to influx through VDCCs11, 26. In cultured hippocampal neurons, about 85% of the nAChR-mediated calcium level changes were blocked by cadmium, a VDCC blocker, suggesting that most of the calcium influx was through VDCCs25. In cultured hippocampal astrocytes13, activation of nAChRs leads to a rapid and large calcium transient. This rise in cytoplasmic calcium level is entirely dependent on direct calcium influx, without any contribution from VDCC activation.

Regulation of neurotransmitter release At presynaptic terminals, the activation of nAChRs can initiate neurotransmitter release directly by raising intraterminal calcium levels due to calcium influx through the channel pore, as well as indirectly by calcium influx through VDCC activation due to membrane depolarization. For example, in hippocampal synaptosomes, the activation of α3β4 nAChRs induced the release of noradrenaline without the involvement of VDCCs38, whereas in striatal dopamine synaptosomes with β2 subunit-containing nAChRs39, the nAChR-induced release of dopamine was mediated by VDCCs38, 40. In addition, presynaptic α7 nAChRs at excitatory synapses can increase the probability of glutamate release in the presence of tetrodotoxin and cadmium41. Lastly in hippocampal mossy fiber terminals, calcium entry through α7 nAChRs can initiate CICR from presynaptic stores, and elicit bursts of miniature excitatory postsynaptic currents42. All of these examples of calcium-dependent neurotransmitter release facilitated by presynaptic nAChRs are consistent with the activation of exocytotic mechanisms43.

Short-term effects

Although electrical signaling and neurotransmitter release related to nAChR activation can occur within milliseconds, downstream events and regulatory feedback mechanisms operate over longer time periods, often requiring seconds to minutes4. These events usually depend on cellular signaling without gene expression, and we will refer to these as 'short-term effects'.

Regulation of neurotransmitter release In addition to inducing neurotransmitter release as noted above, presynaptic nAChRs may also modulate transmitter release through calcium-mediated signal transduction cascades. For example, protein kinase C (PKC) has been proposed to modulate striatal dopamine release by nAChR activation44. Furthermore, nAChR and PKC-mediated stimulation of extracellular signal-regulated mitogen-activated protein kinase (ERK/MAPK)45 and annexin phosphorylation46 have been reported to contribute to the regulation of exocytosis in adrenomedullary cells.

Regulation of nAChR desensitization The nAChRs can undergo desensitization, a reversible reduction in response during sustained agonist application, which has been proposed to be important in controlling synaptic efficacy, responses to cholinergic agents, and certain nAChR-related disease states47. For α7-containing nAChRs in rat hippocampal interneurons48, and for native nAChRs in chromaffin cells49, 50, the recovery from desensitization is delayed by high cytoplasmic calcium levels. This is probably because calcium catalyzes the activity of enzymes such as protein kinase C (PKC) and/or calcineurin, whose dynamic balance controls the recovery process47. In addition, α7 nAChRs on chick ciliary ganglion neurons can undergo substantial activity-dependent inactivation4, 51; this inactivation or rundown depends on receptor activation, calcium influx, calcium release from internal stores, calmodulin, and CaMKII activity.

Long-term effects

A critical element of the long-term consequence of the regulation of synaptic signaling at the cellular level is probably that of transcriptional regulation. In addition to influencing neurotransmitter release, a role for nAChRs in the regulation of cell signaling and gene expression has been reported52. In neuroblastoma cells, exposure to nicotine influences the expression of a diverse set of genes, including transcription and protein-processing factors, and proteins associated with RNA binding and the plasma membrane53. For nAChRs, such transcriptional control is usually triggered by calcium influx directly through the receptors, indirectly through VDCCs, and through release from internal stores4, 54, 55, 56, 57, 58.

Regulation of neurotransmitter release The activation of nAChRs can influence gene expression for immediate early genes and genes involved in transmitter synthesis15, 52, 59, 60. In the chick ciliary ganglion61, the nAChR-mediated control of transcription relies on calcium influx and calcium release from internal stores to activate first CaMKII/IV, and then ERK/MAPK. These enzymes activate the transcription factor CREB (the cAMP response element-binding protein), which can alter gene expression.

As the rate-limiting step in catecholamine biosynthesis, tyrosine hydroxylase (TH) is a major control point in neurotransmitter release from catecholamine-containing neurons, and is subject to diverse regulatory mechanisms62. Long-term treatment with nicotine increases the concentration of TH-mRNA and, consequently, TH-activity, both in vivo and in chromaffin cells62. This effect is calcium-dependent and mediated by protein kinase A (PKA)63. The nicotine-induced activation of expression of the gene encoding TH requires a prolonged increase in calcium concentration, and the activation of store-dependent calcium channels63 and ERK/MAPK64.

Involvement in synaptic plasticity and memory mechanisms Agonists and antagonists of nAChRs can improve and impair performance in cognitive tasks, respectively65. However, elucidating the cellular mechanisms that underlie the contribution of nAChRs to cognitive function is a daunting task. CREB and ERK/MAPK signaling cascades have attracted particular attention because their activities are central to long-term plasticity in the nervous system66. This might have physiological relevance to many functions, including (but not limited to) addiction, learning and memory67. The nAChRs mediate the calcium-dependent activation of ERK/MAPK and CREB in several neuronal models61, 68, 69. The hippocampus has received particular attention as a key area for memory processing, and nAChR-mediated intracellular calcium increases promote activation of CaMKII/IV and ERK/MAPK, and the sustained phosphorylation of CREB69, 70. In addition, in rat brain slices that contain both the ventral tegmental area (VTA) and the nucleus accumbens (NAc), it has been demonstrated71 that activation of presynaptic α7 nAChRs induces long-term potentiation (LTP; a putative cellular model for learning and memory) of the excitatory input to the VTA if nicotine application is paired with postsynaptic stimulation. In hippocampal preparations, presynaptic α7 nAChRs are found to enhance the probability of LTP72. These actions might also contribute to the mechanisms that underlie the effects of nicotine on cognition. Activation of the hippocampal ERK/MAPK pathway is required for the formation of contextual and spatial memories in mammals66. Thus, factors that interfere with the activation of this pathway by α7 nAChRs might contribute to cognitive decline.

Involvement in reward and dependence Drug dependence is thought to involve plastic changes in neuronal circuits that are associated with 'rewarding' behaviours. Nicotine dependence, which is mediated by interaction with nAChRs, is likely to involve the modification of signaling cascades that modulate synaptic plasticity and gene expression, as proposed for other drugs of abuse67, 73, 74. Like other addictive substances and rewarding behaviours, nicotine increases the release of dopamine from the mesolimbic projections to the NAc6, 75. Although somatodendritic nAChRs on dopamine-containing neurons of the VTA can excite these neurons directly, which results in transient responses that are terminated by desensitization of nAChRs76, the stimulation and subsequent desensitization of GABA-containing neurons in the VTA also contributes to an excitatory effect through removal of the inhibitory influence of GABA77.

For nicotine addiction, studies show that in rats, nicotine withdrawal (but not chronic treatment with nicotine itself) significantly reduced the levels of CREB and phosphorylated CREB in rat cortex and the amygdala78. Phosphorylated CREB also decreased in the NAc in mice following chronic consumption of nicotine in their drinking water79. Changes in phosphorylated CREB in the NAc are consistent with previous reports that decreased CREB activity in this region contributes to drug reinforcement80.

Involvement in neuroprotection Nicotine and other nAChR agonists are neuroprotective in several models of neuronal death, both in vivo and in vitro81. The nAChR-mediated neuroprotection against excitotoxicity is calcium-dependent82, 83, 84 and does not involve blockade of glutamate receptor function83, 84, 85. Excessive activation of the N-methyl-D-aspartate (NMDA) receptor is thought to play a prominent role in a variety of acute and chronic neurological injuries86, 87. In hippocampal slices, nicotine-mediated protection against acute NMDA excitotoxicity is mediated by the activation of phosphatidylinositol 3-kinase (PI3K) and the ERK/MAPK pathway84. These signalling molecules could increase the expression of calcium buffering proteins such as calbindin-D28K, which have been implicated in the nAChR-dependent amelioration of excitotoxic insults85. In cortical cultures, the nicotine-induced calcium-dependent activation of the phosphatase calcineurin is proposed to mediate the protection afforded by nicotine against glutamate excitotoxicity88.

Perspectives

Compared to the rapid nAChR-mediated current, the corresponding kinetics of the intracellular calcium response are relatively slow; eg the time-to-peak for nAChR-mediated current responses in dendrites of interneurons was 39 ms, whereas the duration of the calcium response was 7 sec3. In general, the prolonged duration of the evoked Ca2+ response by nAChR stimulation is due to several factors, including (but not limited to) the fact that the intracellular removal mechanisms for calcium are slower, and the secondary Ca2+ release from intracellular stores (eg, the ER and mitochondria) or from the extracellular space via VDCC activation. Thus the relatively large and prolonged Ca2+ accumulation mediated by nAChRs helps these “fast” receptors create prolonged responses at the level of Ca2+ homeostasis3.

The direct and indirect calcium influx resulting from the activation of neuronal nAChRs can generate specific, complex calcium signals that mediate instantaneous (such as presynaptic neurotransmitter release), short-term (such as the modulation of desensitization through cellular signaling) and long-term effects (such as neuroprotection via gene expression). The regulation of calcium signaling is one of the most important aspects induced by the activation of neuronal nAChRs6, which are cell-type, location, and receptor subtype-specific. However the spatial and temporal characteristics of nAChR-mediated calcium signaling are far from understood. In addition, nAChR activity can be regulated by cytoplasmic calcium levels48, 89, 90, suggesting a complex reciprocal relationship. Consistent with this, we recently found that the activation of the M1 muscarinic ACh receptor in hippocampal interneurons decreased the function of the α7 nAChRs in a calcium-dependent manner89.

Physiological roles for neuronal nAChRs continue to be delineated. For example the functions of nAChRs on glia, especially on astrocytes, which occupy about half of the total volume of the brain and are critical for understanding the full picture of various brain functions91, 92, have received considerably less attention to date than for receptors expressed in neurons. However evidence suggests that astrocytic nAChRs may be involved in neuroprotection. Furthermore there may be a role for nAChRs in inflammatory responses in the brain as in the periphery93, 94, 95. The identification of novel gene targets regulated by neuronal nAChR function remains a big challenge, requiring the continued elucidation of the signaling pathways through which nAChRs regulate their expression. The ERK/MAPK signaling cascade is considered to lie at the center of many signaling pathways, and so a particular association with α7 nAChRs in relation to long-term behavioural changes is still waiting to be addressed6.

Although the intracellular mechanism that mediate the modulation of neuronal nAChRs are not fully resolved, further advances in imaging techniques, animal models, and more potent and subtype-selective ligands for nAChRs would almost certainly help in understanding the neuronal nAChR-mediated calcium signaling and lead to better therapeutic treatments.

Acknowledgments

We would like to thank S DUDEK and S B SIMONS for advice in preparing the manuscript. Research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; the National Natural Science Foundation of China (No 30470900), Natural Science Foundation of Guangdong Province (No 04020253) and SRF for ROCS, SEM.

References

  1. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol. 2007;47:699–729. doi: 10.1146/annurev.pharmtox.47.120505.105214. [DOI] [PubMed] [Google Scholar]
  2. McKay BE, Placzek AN, Dani JA. Regulation of synaptic transmission and plasticity by neuronal nicotinic acetylcholine receptors. Biochem Pharmacol. 2007;74:1120–33. doi: 10.1016/j.bcp.2007.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Szabo SI, Zelles T, Lendvai B. Intracellular Ca2+ dynamics of hippocampal interneurons following nicotinic acetylcholine receptor activation. Neurochemistry International. 2008;52:135–41. doi: 10.1016/j.neuint.2007.05.012. [DOI] [PubMed] [Google Scholar]
  4. Berg DK, Conroy WG. Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons. J Neurobiol. 2002;53:512–23. doi: 10.1002/neu.10116. [DOI] [PubMed] [Google Scholar]
  5. Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C, et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci. 2003;23:7820–9. doi: 10.1523/JNEUROSCI.23-21-07820.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dajas-Bailador FA, Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci. 2004;25:317–24. doi: 10.1016/j.tips.2004.04.006. [DOI] [PubMed] [Google Scholar]
  7. Fucile S. Ca2+ permeability of nicotinic acetylcholine receptors. Cell Calcium. 2004;35:1–8. doi: 10.1016/j.ceca.2003.08.006. [DOI] [PubMed] [Google Scholar]
  8. Fayuk D, Yakel JL. Dendritic Ca2+ signalling due to activation of alpha7-containing nicotinic acetylcholine receptors in rat hippocampal neurons. J Physiol. 2007;582:597–611. doi: 10.1113/jphysiol.2007.135319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheng H, Lederer WJ. Calcium sparks. Physiol Rev. 2008;88:1491–545. doi: 10.1152/physrev.00030.2007. [DOI] [PubMed] [Google Scholar]
  10. Clapham DE. Calcium signaling. Cell. 2007;131:1047–58. doi: 10.1016/j.cell.2007.11.028. [DOI] [PubMed] [Google Scholar]
  11. Rathouz MM, Berg DK. Synaptic–type acetylcholine receptors raise intracellular calcium levels in neurons by two mechanisms. J Neurosci. 1994;14:6935–45. doi: 10.1523/JNEUROSCI.14-11-06935.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tsuneki H, Klink R, Lena C, Korn H, Changeux JP. Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta. Eur J Neurosci. 2000;12:2475–85. doi: 10.1046/j.1460-9568.2000.00138.x. [DOI] [PubMed] [Google Scholar]
  13. Sharma G, Vijayaraghavan S. Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci USA. 2001;98:4148–53. doi: 10.1073/pnas.071540198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dajas-Bailador FA, Mogg AJ, Wonnacott S. Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca2+ channels and Ca2+ stores. J Neurochem. 2002;81:606–14. doi: 10.1046/j.1471-4159.2002.00846.x. [DOI] [PubMed] [Google Scholar]
  15. Gueorguiev VD, Zeman RJ, Meyer EM, Sabban EL. Involvement of alpha7 nicotinic acetylcholine receptors in activation of tyrosine hydroxylase and dopamine beta-hydroxylase gene expression in PC12 cells. J Neurochem. 2000;75:1997–2005. doi: 10.1046/j.1471-4159.2000.0751997.x. [DOI] [PubMed] [Google Scholar]
  16. Lassignal NL, Martin AR. Effect of acetylcholine on postjunctional membrane permeability in eel electroplaque. J Gen Physiol. 1977;70:23–36. doi: 10.1085/jgp.70.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lewis CA. Ion-concentration dependence of the reversal potential and the single channel conductance of ion channels at the frog neuromuscular junction. J Physiol. 1979;286:417–45. doi: 10.1113/jphysiol.1979.sp012629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440–50. [PubMed] [Google Scholar]
  19. Zhou Z, Neher E. Calcium permeability of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells. Pflugers Arch. 1993;425:511–7. doi: 10.1007/BF00374879. [DOI] [PubMed] [Google Scholar]
  20. Neher E. The use of fura-2 for estimating Ca buffers and Ca fluxes. Neuropharmacology. 1995;34:1423–42. doi: 10.1016/0028-3908(95)00144-u. [DOI] [PubMed] [Google Scholar]
  21. Fucile S, Renzi M, Lax P, Eusebi F. Fractional Ca2+ current through human neuronal alpha7 nicotinic acetylcholine receptors. Cell Calcium. 2003;34:205–9. doi: 10.1016/s0143-4160(03)00071-x. [DOI] [PubMed] [Google Scholar]
  22. Gerzanich V, Wang F, Kuryatov A, Lindstrom J. alpha5 Subunit alters desensitization, pharmacology, Ca2+ permeability and Ca2+ modulation of human neuronal alpha3 nicotinic receptors. J Pharmacol Exp Ther. 1998;286:311–20. [PubMed] [Google Scholar]
  23. Tapia L, Kuryatov A, Lindstrom J. Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors. Mol Pharmacol. 2007;71:769–76. doi: 10.1124/mol.106.030445. [DOI] [PubMed] [Google Scholar]
  24. Shoop RD, Chang KT, Ellisman MH, Berg DK. Synaptically driven calcium transients via nicotinic receptors on somatic spines. J Neurosci. 2001;21:771–81. doi: 10.1523/JNEUROSCI.21-03-00771.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Barrantes GE, Murphy CT, Westwick J, Wonnacott S. Nicotine increases intracellular calcium in rat hippocampal neurons via voltage-gated calcium channels. Neurosci Lett. 1995;196:101–4. doi: 10.1016/0304-3940(95)11859-u. [DOI] [PubMed] [Google Scholar]
  26. Vijayaraghavan S, Pugh PC, Zhang ZW, Rathouz MM, Berg DK. Nicotinic receptors that bind alpha-bungarotoxin on neurons raise intracellular free Ca2+ Neuron. 1992;8:353–62. doi: 10.1016/0896-6273(92)90301-s. [DOI] [PubMed] [Google Scholar]
  27. Mulle C, Choquet D, Korn H, Changeux JP. Calcium influx through nicotinic receptor in rat central neurons: its relevance to cellular regulation. Neuron. 1992;8:135–43. doi: 10.1016/0896-6273(92)90115-t. [DOI] [PubMed] [Google Scholar]
  28. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4:517–29. doi: 10.1038/nrm1155. [DOI] [PubMed] [Google Scholar]
  29. Eberhard DA, Holz RW. Cholinergic stimulation of inositol phosphate formation in bovine adrenal chromaffin cells: distinct nicotinic and muscarinic mechanisms. J Neurochem. 1987;49:1634–43. doi: 10.1111/j.1471-4159.1987.tb01037.x. [DOI] [PubMed] [Google Scholar]
  30. Yang J, McBride S, Mak DO, Vardi N, Palczewski K, Haeseleer F, et al. Identification of a family of calcium sensors as protein ligands of inositol trisphosphate receptor Ca2+ release channels. Proc Natl Acad Sci USA. 2002;99:7711–6. doi: 10.1073/pnas.102006299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Murchison D, Griffith WH. Mitochondria buffer non–toxic calcium loads and release calcium through the mitochondrial permeability transition pore and sodium/calcium exchanger in rat basal forebrain neurons. Brain Res. 2000;854:139–51. doi: 10.1016/s0006-8993(99)02297-0. [DOI] [PubMed] [Google Scholar]
  32. Arnaudeau S, Kelley WL, Walsh JV, Jr, Demaurex N. Mitochondria recycle Ca(2+) to the endoplasmic reticulum and prevent the depletion of neighboring endoplasmic reticulum regions. J Biol Chem. 2001;276:29430–9. doi: 10.1074/jbc.M103274200. [DOI] [PubMed] [Google Scholar]
  33. Malli R, Frieden M, Trenker M, Graier WF. The role of mitochondria for Ca2+ refilling of the endoplasmic reticulum. J Biol Chem. 2005;280:12114–22. doi: 10.1074/jbc.M409353200. [DOI] [PubMed] [Google Scholar]
  34. Graier WF, Frieden M, Malli R. Mitochondria and Ca2+ signaling: old guests, new functions. Pflugers Arch. 2007;455:375–96. doi: 10.1007/s00424-007-0296-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rizzuto R, Pozzan T. Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev. 2006;86:369–408. doi: 10.1152/physrev.00004.2005. [DOI] [PubMed] [Google Scholar]
  36. Ferroni S, Marchini C, Ogata T, Schubert P. Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes. J Neurosci Res. 2002;68:615–21. doi: 10.1002/jnr.10248. [DOI] [PubMed] [Google Scholar]
  37. Rui Y, Tiwari P, Xie Z, Zheng JQ. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci. 2006;26:10480–7. doi: 10.1523/JNEUROSCI.3231-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kulak JM, McIntosh JM, Yoshikami D, Olivera BM. Nicotine-evoked transmitter release from synaptosomes: functional association of specific presynaptic acetylcholine receptors and voltage-gated calcium channels. J Neurochem. 2001;77:1581–9. doi: 10.1046/j.1471-4159.2001.00357.x. [DOI] [PubMed] [Google Scholar]
  39. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C. Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci. 2002;22:8785–9. doi: 10.1523/JNEUROSCI.22-20-08785.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Soliakov L, Wonnacott S. Voltage-sensitive Ca2+ channels involved in nicotinic receptor-mediated 3H]dopamine release from rat striatal synaptosomes. J Neurochem. 1996;67:163–70. doi: 10.1046/j.1471-4159.1996.67010163.x. [DOI] [PubMed] [Google Scholar]
  41. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 1996;383:713–6. doi: 10.1038/383713a0. [DOI] [PubMed] [Google Scholar]
  42. Sharma G, Vijayaraghavan S. Modulation of Presynaptic Store Calcium Induces Release of Glutamate and Postsynaptic Firing. Neuron. 2003;38:929–39. doi: 10.1016/s0896-6273(03)00322-2. [DOI] [PubMed] [Google Scholar]
  43. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 1997;20:92–8. doi: 10.1016/s0166-2236(96)10073-4. [DOI] [PubMed] [Google Scholar]
  44. Soliakov L, Wonnacott S. Involvement of protein kinase C in the presynaptic nicotinic modulation of [3H]-dopamine release from rat striatal synaptosomes. Br J Pharmacol. 2001;132:785–91. doi: 10.1038/sj.bjp.0703873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Cox ME, Parsons SJ. Roles for protein kinase C and mitogen-activated protein kinase in nicotine-induced secretion from bovine adrenal chromaffin cells. J Neurochem. 1997;69:1119–30. doi: 10.1046/j.1471-4159.1997.69031119.x. [DOI] [PubMed] [Google Scholar]
  46. Delouche B, Pradel LA, Henry JP. Phosphorylation by protein kinase C of annexin 2 in chromaffin cells stimulated by nicotine. J Neurochem. 1997;68:1720–7. doi: 10.1046/j.1471-4159.1997.68041720.x. [DOI] [PubMed] [Google Scholar]
  47. Giniatullin R, Nistri A, Yakel JL. Desensitization of nicotinic ACh receptors: shaping cholinergic signaling. Trends Neurosci. 2005;28:371–8. doi: 10.1016/j.tins.2005.04.009. [DOI] [PubMed] [Google Scholar]
  48. Khiroug L, Giniatullin R, Klein RC, Fayuk D, Yakel JL. Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons. J Neurosci. 2003;23:9024–31. doi: 10.1523/JNEUROSCI.23-27-09024.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Khiroug L, Giniatullin R, Sokolova E, Talantova M, Nistri A. Imaging of intracellular calcium during desensitization of nicotinic acetylcholine receptors of rat chromaffin cells. Br J Pharmacol. 1997;122:1323–32. doi: 10.1038/sj.bjp.0701518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Khiroug L, Sokolova E, Giniatullin R, Afzalov R, Nistri A. Recovery from desensitization of neuronal nicotinic acetylcholine receptors of rat chromaffin cells is modulated by intracellular calcium through distinct second messengers. J Neurosci. 1998;18:2458–66. doi: 10.1523/JNEUROSCI.18-07-02458.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Liu Q, Berg DK. Actin filaments and the opposing actions of CaM kinase II and calcineurin in regulating alpha7-containing nicotinic receptors on chick ciliary ganglion neurons. J Neurosci. 1999;19:10280–8. doi: 10.1523/JNEUROSCI.19-23-10280.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Greenberg ME, Ziff EB, Greene LA. Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science. 1986;234:80–3. doi: 10.1126/science.3749894. [DOI] [PubMed] [Google Scholar]
  53. Dunckley T, Lukas RJ. Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell line. J Biol Chem. 2003;278:15633–40. doi: 10.1074/jbc.M210389200. [DOI] [PubMed] [Google Scholar]
  54. Mermelstein PG, Bito H, Deisseroth K, Tsien RW. Critical dependence of cAMP response element-binding protein phosphorylation on L-type calcium channels supports a selective response to EPSPs in preference to action potentials. J Neurosci. 2000;20:266–73. doi: 10.1523/JNEUROSCI.20-01-00266.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Hardingham GE, Arnold FJ, Bading H. Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat Neurosci. 2001;4:261–7. doi: 10.1038/85109. [DOI] [PubMed] [Google Scholar]
  56. Deisseroth K, Bito H, Tsien RW. Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity. Neuron. 1996;16:89–101. doi: 10.1016/s0896-6273(00)80026-4. [DOI] [PubMed] [Google Scholar]
  57. Bito H, Takemoto-Kimura S. Ca2+/CREB/CBP-dependent gene regulation: a shared mechanism critical in long-term synaptic plasticity and neuronal survival. Cell Calcium. 2003;34:425–30. doi: 10.1016/s0143-4160(03)00140-4. [DOI] [PubMed] [Google Scholar]
  58. Bito H. The role of calcium in activity-dependent neuronal gene regulation. Cell Calcium. 1998;23:143–50. doi: 10.1016/s0143-4160(98)90113-0. [DOI] [PubMed] [Google Scholar]
  59. Pelto-Huikko M, Dagerlind A, Kononen J, Lundberg JM, Villar M, Koistinaho J, et al. Neuronal regulation of c-fos, c-jun, and junB immediate-early genes in rat adrenal medulla. J Neurosci. 1995;15:1854–68. doi: 10.1523/JNEUROSCI.15-03-01854.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Salminen O, Seppa T, Gaddnas H, Ahtee L. The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal. J Neurosci. 1999;19:8145–51. doi: 10.1523/JNEUROSCI.19-18-08145.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Chang KT, Berg DK. Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons. Neuron. 2001;32:855–65. doi: 10.1016/s0896-6273(01)00516-5. [DOI] [PubMed] [Google Scholar]
  62. Kumer SC, Vrana KE. Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem. 1996;67:443–62. doi: 10.1046/j.1471-4159.1996.67020443.x. [DOI] [PubMed] [Google Scholar]
  63. Gueorguiev VD, Zeman RJ, Hiremagalur B, Menezes A, Sabban EL. Differing temporal roles of Ca2+ and cAMP in nicotine-elicited elevation of tyrosine hydroxylase mRNA. Am J Physiol. 1999;276:C54–65. doi: 10.1152/ajpcell.1999.276.1.C54. [DOI] [PubMed] [Google Scholar]
  64. Griffiths J, Marley PD. Ca2+-dependent activation of tyrosine hydroxylase involves MEK1. Neuroreport. 2001;12:2679–83. doi: 10.1097/00001756-200108280-00018. [DOI] [PubMed] [Google Scholar]
  65. Levin ED, Simon BB. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 1998;138:217–30. doi: 10.1007/s002130050667. [DOI] [PubMed] [Google Scholar]
  66. Sweatt JD. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem. 2001;76:1–10. doi: 10.1046/j.1471-4159.2001.00054.x. [DOI] [PubMed] [Google Scholar]
  67. Nestler EJ. Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem. 2002;78:637–47. doi: 10.1006/nlme.2002.4084. [DOI] [PubMed] [Google Scholar]
  68. Nakayama H, Numakawa T, Ikeuchi T, Hatanaka H. Nicotine-induced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells. J Neurochem. 2001;79:489–98. doi: 10.1046/j.1471-4159.2001.00602.x. [DOI] [PubMed] [Google Scholar]
  69. Dajas-Bailador FA, Soliakov L, Wonnacott S. Nicotine activates the extracellular signal-regulated kinase 1/2 via the alpha7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones. J Neurochem. 2002;80:520–30. doi: 10.1046/j.0022-3042.2001.00725.x. [DOI] [PubMed] [Google Scholar]
  70. Hu M, Liu QS, Chang KT, Berg DK. Nicotinic regulation of CREB activation in hippocampal neurons by glutamatergic and nonglutamatergic pathways. Mol Cell Neurosci. 2002;21:616–25. doi: 10.1006/mcne.2002.1202. [DOI] [PubMed] [Google Scholar]
  71. Mansvelder HD, McGehee DS. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron. 2000;27:349–57. doi: 10.1016/s0896-6273(00)00042-8. [DOI] [PubMed] [Google Scholar]
  72. Ji D, Lape R, Dani JA. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron. 2001;31:131–41. doi: 10.1016/s0896-6273(01)00332-4. [DOI] [PubMed] [Google Scholar]
  73. Dani JA, Ji D, Zhou FM. Synaptic plasticity and nicotine addiction. Neuron. 2001;31:349–52. doi: 10.1016/s0896-6273(01)00379-8. [DOI] [PubMed] [Google Scholar]
  74. Placzek AN, Dani JA. Synaptic plasticity within midbrain dopamine centers contributes to nicotine addiction. Nebr Symp Motiv. 2009;55:5–15. doi: 10.1007/978-0-387-78748-0_2. [DOI] [PubMed] [Google Scholar]
  75. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988;85:5274–8. doi: 10.1073/pnas.85.14.5274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA. Nicotine activates and desensitizes midbrain dopamine neurons. Nature. 1997;390:401–4. doi: 10.1038/37120. [DOI] [PubMed] [Google Scholar]
  77. Laviolette SR, van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci. 2004;5:55–65. doi: 10.1038/nrn1298. [DOI] [PubMed] [Google Scholar]
  78. Pandey SC, Roy A, Xu T, Mittal N. Effects of protracted nicotine exposure and withdrawal on the expression and phosphorylation of the CREB gene transcription factor in rat brain. J Neurochem. 2001;77:943–52. doi: 10.1046/j.1471-4159.2001.00309.x. [DOI] [PubMed] [Google Scholar]
  79. Brunzell DH, Russell DS, Picciotto MR. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J Neurochem. 2003;84:1431–41. doi: 10.1046/j.1471-4159.2003.01640.x. [DOI] [PubMed] [Google Scholar]
  80. Barrot M, Olivier JD, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, et al. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci USA. 2002;99:11435–40. doi: 10.1073/pnas.172091899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. O'Neill MJ, Murray TK, Lakics V, Visanji NP, Duty S. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr Drug Targets CNS Neurol Disord. 2002;1:399–411. doi: 10.2174/1568007023339166. [DOI] [PubMed] [Google Scholar]
  82. Donnelly-Roberts DL, Xue IC, Arneric SP, Sullivan JP. In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418. Brain Res. 1996;719:36–44. doi: 10.1016/0006-8993(96)00063-7. [DOI] [PubMed] [Google Scholar]
  83. Dajas-Bailador FA, Lima PA, Wonnacott S. The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca2+ dependent mechanism. Neuropharmacology. 2000;39:2799–807. doi: 10.1016/s0028-3908(00)00127-1. [DOI] [PubMed] [Google Scholar]
  84. Ferchmin PA, Perez D, Eterovic VA, de Vellis J. Nicotinic receptors differentially regulate N-methyl-D-aspartate damage in acute hippocampal slices. J Pharmacol Exp Ther. 2003;305:1071–8. doi: 10.1124/jpet.102.048173. [DOI] [PubMed] [Google Scholar]
  85. Prendergast MA, Harris BR, Mayer S, Holley RC, Hauser KF, Littleton JM. Chronic nicotine exposure reduces N-methyl-D-aspartate receptor-mediated damage in the hippocampus without altering calcium accumulation or extrusion: evidence of calbindin–D28K overexpression. Neuroscience. 2001;102:75–85. doi: 10.1016/s0306-4522(00)00450-4. [DOI] [PubMed] [Google Scholar]
  86. Wang XQ, Peng YP, Lu JH, Cao BB, Qiu YH. Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK. Neurosci Lett. 2009;450:122–6. doi: 10.1016/j.neulet.2008.11.051. [DOI] [PubMed] [Google Scholar]
  87. Mandir AS, Poitras MF, Berliner AR, Herring WJ, Guastella DB, Feldman A, et al. NMDA but not non-NMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase. J Neurosci. 2000;20:8005–11. doi: 10.1523/JNEUROSCI.20-21-08005.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Stevens TR, Krueger SR, Fitzsimonds RM, Picciotto MR. Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation. J Neurosci. 2003;23:10093–9. doi: 10.1523/JNEUROSCI.23-31-10093.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Shen JX, Tu B, Yakel JL. Inhibition of alpha7-containing nicotinic ACh receptors by muscarinic M1 ACh receptors in rat hippocampal CA1 interneurons in slices. J Physiol. 2009;587:1033–42. doi: 10.1113/jphysiol.2008.167593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Quick MW, Lester RA. Desensitization of neuronal nicotinic receptors. J Neurobiol. 2002;53:457–78. doi: 10.1002/neu.10109. [DOI] [PubMed] [Google Scholar]
  91. Agulhon C, Petravicz J, McMullen AB, Sweger EJ, Minton SK, Taves SR, et al. What is the role of astrocyte calcium in neurophysiology. Neuron. 2008;59:932–46. doi: 10.1016/j.neuron.2008.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Barres BA. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron. 2008;60:430–40. doi: 10.1016/j.neuron.2008.10.013. [DOI] [PubMed] [Google Scholar]
  93. Pavlov VA, Parrish WR, Rosas–Ballina M, Ochani M, Puerta M, Ochani K, et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun. 2009;23:41–5. doi: 10.1016/j.bbi.2008.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Gallowitsch-Puerta M, Tracey KJ. Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha7 receptor. Ann N Y Acad Sci. 2005;1062:209–19. doi: 10.1196/annals.1358.024. [DOI] [PubMed] [Google Scholar]
  95. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384–8. doi: 10.1038/nature01339. [DOI] [PubMed] [Google Scholar]

Articles from Acta Pharmacologica Sinica are provided here courtesy of Nature Publishing Group

RESOURCES